APA

Arozal W., Watanabe K., Veeraveedu P. T., Thandavarayan R. A., Harima M., Sukumaran V., Suzuki K., Tachikawa H., Kodama M. & Aizawa Y. (20110125). Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. : Free radical research.

Chicago

Arozal Wawaimuli, Watanabe Kenichi, Veeraveedu Punniyakoti T, Thandavarayan Rajarajan A, Harima Meilei, Sukumaran Vijayakumar, Suzuki Kenji, Tachikawa Hitoshi, Kodama Makoto and Aizawa Yoshifusa. 20110125. Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. : Free radical research.

Harvard

Arozal W., Watanabe K., Veeraveedu P. T., Thandavarayan R. A., Harima M., Sukumaran V., Suzuki K., Tachikawa H., Kodama M. and Aizawa Y. (20110125). Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. : Free radical research.

MLA

Arozal Wawaimuli, Watanabe Kenichi, Veeraveedu Punniyakoti T, Thandavarayan Rajarajan A, Harima Meilei, Sukumaran Vijayakumar, Suzuki Kenji, Tachikawa Hitoshi, Kodama Makoto and Aizawa Yoshifusa. Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. : Free radical research. 20110125.